American Society of Hematology

SHERPA: Blue

People

  1. Scheinberg
    Scheinberg
  2. Mcdevitt
    Mcdevitt
  3. O'Reilly
    O'Reilly
  4. Pandit-Taskar
    Pandit-Taskar
  5. Sadelain
    Sadelain
  6. Caron
    Caron
  7. Ballangrud-Popovic
    Ballangrud-Popovic
  8. Carrasquillo
    Carrasquillo
  9. Castro-Malaspina
    Castro-Malaspina
  10. Devlin
    Devlin

Groups

  1. Center for Hematologic Malignancies (18)
  2. Department of Medicine (18)
  3. GSK Faculty (18)
  4. Hematologic Malignancies, Division of (18)
  5. Molecular Imaging and Therapy Service (18)
  6. Radiology, Department of (18)
  7. Sloan Kettering Institute Faculty (18)
  8. Molecular Pharmacology and Chemistry Program Faculty (17)
  9. Hematologic Malignancies Research (15)
  10. Tow Center for Developmental Oncology (TCDO) (14)
Search Within
  1. "Sloan Kettering Institute Faculty"
  2. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (18)
  2. Department of Medicine (18)
  3. GSK Faculty (18)
  4. Hematologic Malignancies, Division of (18)
  5. Molecular Imaging and Therapy Service (18)
  6. Radiology, Department of (18)

More Groups

People
  1. Steven Larson (16)
  2. David Scheinberg (11)
  3. Joseph Jurcic (10)
  4. Ronald Finn (9)
  5. Michael Mcdevitt (8)
  6. Chaitanya Divgi (5)

More People

Years
  1. 2023 (1)
  2. 2017 (1)
  3. 2011 (1)
  4. 2008 (2)
  5. 2007 (1)
  6. 2006 (1)

More Years

Publications
  1. Blood (18)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Cho, C.; Maloy, M.; Devlin, S. M.; Aras, O.; Castro-Malaspina, H. R.; Dauer, L. T.; Jakubowski, A. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Perales, M. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Cdk4/6 inhibitor PD 0332991 demonstrates cell cycle inhibition via FLT-PET imaging and tissue analysis in patients with recurrent mantle cell lymphoma
    Meeting Abstract

    Leonard, J. P.; LaCasce, A.; Smith, M. R.; Noy, A.; Yap, J. T.; Van Den Abbeele, A. D.; Yu, J. Q.; Chen-Kiang, S.; Ely, S. A.; Vallabhajosula, S.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Sensitive in vivo detection of primary T cells expressing membrane anchored Gaussia luciferase for the study of adoptive T cell immunotherapy in murine models of malignancy
    Meeting Abstract

    Brentjens, R. J.; Santos, E.; Yeh, R.; La Perle, K.; Toledo-Crow, R.; Nikhamin, Y.; Punzalan, B.; Entenberg, D.; Aranda, I.; Larson, S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • Long-term in vivo monitoring of the tumor targeted migration of EBV specific cytotoxic T-cells transduced to express HSV-TK by PET scan following repeated in vivo labeling with [I-124]FIAU
    Meeting Abstract

    Doubrovina, E. S.; Doubrovin, M. M.; Ivanova, A.; Ageyeva, L.; Balatoni, J.; Beresten, T.; Finn, R.; Larson, S.; Sadelain, M.; Blasberg, R.; more...
    Blood (2002)

    Fulltext@MSK | Save